A61P 19/04
Drugs for skeletal disorders: for non-specific disorders of the connective tissue
Official title: for non-specific disorders of the connective tissue
A61P19/04 (Drugs for skeletal disorders: for non-specific disorders of the connective tissue) appears on 2,701 US grants and 4,467 published applications in this corpus.
Search patents in A61P- Granted patents
- 2,701
- Published applications
- 4,467
- Assignees
- 1,694
- Inventors
- 7,647
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 10 | 0 |
| 1999 | 12 | 0 |
| 2000 | 13 | 0 |
| 2001 | 19 | 12 |
| 2002 | 39 | 71 |
| 2003 | 37 | 114 |
| 2004 | 26 | 171 |
| 2005 | 38 | 174 |
| 2006 | 72 | 182 |
| 2007 | 63 | 177 |
| 2008 | 80 | 212 |
| 2009 | 65 | 218 |
| 2010 | 146 | 301 |
| 2011 | 171 | 323 |
| 2012 | 195 | 439 |
| 2013 | 235 | 256 |
| 2014 | 243 | 246 |
| 2015 | 225 | 225 |
| 2016 | 169 | 209 |
| 2017 | 146 | 187 |
| 2018 | 127 | 154 |
| 2019 | 141 | 161 |
| 2020 | 92 | 126 |
| 2021 | 87 | 122 |
| 2022 | 55 | 114 |
| 2023 | 48 | 92 |
| 2024 | 53 | 80 |
| 2025 | 54 | 66 |
| 2026 | 31 | 35 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Polymeric patch scaffolds for articular cartilage regeneration6 Oct 2026US 12,752,041 B2University of Southern California
- Method for manufacturing mitochondria-rich plasma22 Sep 2026US 12,741,068 B2Taiwan Mitochondrion Applied Technology Co., Ltd.
- Dopamine receptor d1 agonists and methods of use22 Sep 2026US 12,741,940 B2Mayo Foundation for Medical Education and Research
- Cannabinoids, pharmaceutical compositions comprising same and uses thereof25 Aug 2026US 12,714,719 B2
- Method of in vitro chondrocyte and cartilage culture to obtain material for the treatment of articular cartilage defects25 Aug 2026US 12,714,766 B2Arthec S.A.
- Methods Of Treating Plantar Fibromatosis1 Oct 2026US 2026/0295023 A1
- N-cyanopyrrolidines with activity as usp30 inhibitors1 Oct 2026US 2026/0297075 A1Mission Therapeutics Limited
- Treatment of intervertebral disc degeneration3 Sep 2026US 2026/0256847 A1Kolon Tissuegene, Inc.
- Method for cartilage regeneration and regrowth following injury27 Aug 2026US 2026/0248722 A1Eluciderm Inc.
- Repair and/or reconstruction of invertebral discs20 Aug 2026US 2026/0240918 A1Mesoblast, Inc.
Most cited
By later US patents
- Plasma protein matrices and methods for their preparation1,406US 7,009,039 B2ProChon Biotech Ltd. · 2006
- Sustained release systems of ascorbic acid phosphate1,391US 8,034,363 B2Advanced Technologies and Regenerative Medicine, LLC · 2011
- Segmented delivery system1,003US 9,101,475 B2Warsaw Orthopedic, Inc. · 2015
- Three dimensional cell protector/pore architecture formation for bone and tissue constructs778US 7,713,542 B2ADA Foundation · 2010
- Method for repair of ligament or tendon659US 9,649,190 B2TRB Chemedica International S.A. · 2017